Market Cap 8.39B
Revenue (ttm) 3.44B
Net Income (ttm) -8.60M
EPS (ttm) N/A
PE Ratio 33.85
Forward PE 26.70
Profit Margin -0.25%
Debt to Equity Ratio 0.68
Volume 1,865,100
Avg Vol 2,561,620
Day's Range N/A - N/A
Shares Out 152.23M
Stochastic %K 43%
Beta 1.31
Analysts Sell
Price Target $53.25

Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative...

Industry: Medical Devices
Sector: Healthcare
Phone: 978 663 3660
Fax: 978 663 5585
Address:
40 Manning Road, Billerica, United States
Esau815
Esau815 Jun. 20 at 11:17 PM
$BRKR Wait a minute. Just read the proxy. Jack Phillips is the "accomplished executive" who is new to the Board??? He's the guy who bankrupted AXDX! How did he get this soft landing?
0 · Reply
Thos01
Thos01 Jun. 18 at 5:52 PM
$BRKR damn this looks pretty good
0 · Reply
SuperGreenToday
SuperGreenToday Jun. 16 at 10:03 PM
$BRKR Share Price: $55.79 Contract Selected: Dec 18, 2026 $55 Calls Buy Zone: $8.50 – $10.50 Target Zone: $13.61 – $16.64 Potential Upside: 51% ROI Time to Expiration: 184 Days | Updates via https://fxcapta.com/stockinfo/
1 · Reply
MarketBeat
MarketBeat Jun. 6 at 8:03 PM
https://marketbeat.com/a/8696951/ $BRKR Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam
0 · Reply
YoloSqueeze
YoloSqueeze Jun. 3 at 2:46 PM
$SMCI if we wanted to move, we would be doing what $BRKR is doing
0 · Reply
DavyDaveCharts
DavyDaveCharts May. 28 at 3:54 PM
$BRKR 18% in 7 days.
0 · Reply
DavyDaveCharts
DavyDaveCharts May. 21 at 9:13 PM
$BRKR monthly: nice bounce from the bullish imbalance. looking at 56 as a draw on liquidity. Momentum indicators are bullish.
0 · Reply
stockpicker63
stockpicker63 May. 6 at 6:58 PM
Watch $BRKR
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 6 at 10:37 AM
$BRKR Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.02 down -81.82% YoY • Reported revenue of $823.4M up 2.75% YoY • Bruker reconfirms FY2026 guidance, expecting revenues of $3.57B, an increase of 4% to 5% year-over-year, with 1% to 2% organic growth. Non-GAAP EPS is projected to be $2.10 to $2.15, up 15% to 17% year-over-year.
0 · Reply
Ren_Stimpy
Ren_Stimpy May. 1 at 11:59 AM
$STIM $BRKR $BIO $AHCO $ENOV this is just a few examples of companies in the medical device industry that sold more of their shares than they currently have. Add up the percentage of institutional, insiders and shares shorted. All well over 💯 percent!! How will the short sellers buy back shares that don’t exist? I think short sellers are in trouble of losing big betting against this industry.
0 · Reply
Latest News on BRKR
Bruker price target raised to $60 from $53 at Barclays

2026-06-24T08:50:08.000Z - 22 hours ago

Bruker price target raised to $60 from $53 at Barclays


The Healthcare M&A Wave

Jun 17, 2026, 12:30 PM EDT - 7 days ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX


Bruker files automatic mixed securities shelf

2026-06-12T20:20:36.000Z - 12 days ago

Bruker files automatic mixed securities shelf


Quanterix appoints Faessler as Chief Financial Officer

2026-06-09T12:11:58.000Z - 15 days ago

Quanterix appoints Faessler as Chief Financial Officer

QTRX


Bruker price target raised to $65 from $45 at JPMorgan

2026-06-08T11:38:53.000Z - 16 days ago

Bruker price target raised to $65 from $45 at JPMorgan


Bruker Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 11:40 AM EDT - 20 days ago

Bruker Transcript: Jefferies Global Healthcare Conference 2026


Bruker price target raised to $65 from $49 at BofA

2026-06-02T11:37:45.000Z - 22 days ago

Bruker price target raised to $65 from $49 at BofA


Bruker announces launch of timsMRMS system

2026-06-01T11:09:08.000Z - 23 days ago

Bruker announces launch of timsMRMS system


Bruker participates in a conference call with Jefferies

2026-05-29T17:31:07.000Z - 26 days ago

Bruker participates in a conference call with Jefferies


Bruker Transcript: AGM 2026

May 21, 2026, 10:00 AM EDT - 4 weeks ago

Bruker Transcript: AGM 2026


Bruker price target raised to $45 from $40 at Stifel

2026-05-08T13:10:34.000Z - 6 weeks ago

Bruker price target raised to $45 from $40 at Stifel


Bruker price target raised to $45 from $43 at TD Cowen

2026-05-07T20:19:32.000Z - 6 weeks ago

Bruker price target raised to $45 from $43 at TD Cowen


Bruker price target raised to $45 from $40 at UBS

2026-05-07T14:17:50.000Z - 6 weeks ago

Bruker price target raised to $45 from $40 at UBS


Bruker price target raised to $53 from $45 at Barclays

2026-05-07T12:07:54.000Z - 6 weeks ago

Bruker price target raised to $53 from $45 at Barclays


Bruker price target raised to $44 from $40 at Citi

2026-05-07T10:51:26.000Z - 6 weeks ago

Bruker price target raised to $44 from $40 at Citi


Bruker reports Q1 adjusted EPS 31c, consensus 23c

2026-05-07T09:37:03.000Z - 6 weeks ago

Bruker reports Q1 adjusted EPS 31c, consensus 23c


Bruker Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 7 weeks ago

Bruker Earnings Call Transcript: Q1 2026


Bruker Earnings release: Q1 2026

May 6, 2026, 8:00 AM EDT - 7 weeks ago

Bruker Earnings release: Q1 2026


Bruker Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 7 weeks ago

Bruker Slides: Q1 2026


Bruker Quarterly report: Q1 2026

May 6, 2026, 8:00 AM EDT - 7 weeks ago

Bruker Quarterly report: Q1 2026


Bruker Reports First Quarter 2026 Financial Results

May 6, 2026, 6:30 AM EDT - 7 weeks ago

Bruker Reports First Quarter 2026 Financial Results


Bruker Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 2 months ago

Bruker Proxy statement: Proxy filing


Bruker Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 2 months ago

Bruker Proxy statement: Proxy filing


Bruker Earnings Call Transcript: Q4 2025

Feb 12, 2026, 8:30 AM EST - 4 months ago

Bruker Earnings Call Transcript: Q4 2025


Bruker Annual report: Q4 2025

Feb 12, 2026, 8:30 AM EST - 4 months ago

Bruker Annual report: Q4 2025


Bruker Earnings release: Q4 2025

Feb 12, 2026, 8:30 AM EST - 4 months ago

Bruker Earnings release: Q4 2025


Bruker Slides: Q4 2025

Feb 12, 2026, 8:30 AM EST - 4 months ago

Bruker Slides: Q4 2025


Bruker Announces Quarterly Preferred Stock Dividend

Feb 5, 2026, 4:05 PM EST - 4 months ago

Bruker Announces Quarterly Preferred Stock Dividend


Bruker Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 12:00 PM EST - 5 months ago

Bruker Transcript: 44th Annual J.P. Morgan Healthcare Conference


Bruker Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 12:00 PM EST - 5 months ago

Bruker Slides: 44th Annual J.P. Morgan Healthcare Conference


Bruker Transcript: 53rd Annual Nasdaq Investor Conference

Dec 10, 2025, 5:00 AM EST - 7 months ago

Bruker Transcript: 53rd Annual Nasdaq Investor Conference


Indaba Capital Announces Sale of AST Revolution to Bruker

Nov 24, 2025, 9:00 AM EST - 7 months ago

Indaba Capital Announces Sale of AST Revolution to Bruker


Bruker Transcript: Wolfe Research Healthcare Conference 2025

Nov 17, 2025, 4:00 PM EST - 7 months ago

Bruker Transcript: Wolfe Research Healthcare Conference 2025


Bruker Earnings Call Transcript: Q3 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

Bruker Earnings Call Transcript: Q3 2025


Bruker Quarterly report: Q3 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

Bruker Quarterly report: Q3 2025


Bruker Earnings release: Q3 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

Bruker Earnings release: Q3 2025


Bruker Slides: Q3 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

Bruker Slides: Q3 2025


Bruker Reports Third Quarter 2025 Financial Results

Nov 3, 2025, 7:00 AM EST - 8 months ago

Bruker Reports Third Quarter 2025 Financial Results


Bruker Announces Quarterly Dividend

Aug 12, 2025, 7:00 AM EDT - 11 months ago

Bruker Announces Quarterly Dividend


Bruker Earnings Call Transcript: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 11 months ago

Bruker Earnings Call Transcript: Q2 2025


Bruker Quarterly report: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 11 months ago

Bruker Quarterly report: Q2 2025


Bruker Earnings release: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 11 months ago

Bruker Earnings release: Q2 2025


Bruker Slides: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 11 months ago

Bruker Slides: Q2 2025


Bruker Reports Second Quarter 2025 Financial Results

Aug 4, 2025, 7:00 AM EDT - 11 months ago

Bruker Reports Second Quarter 2025 Financial Results


Bruker Launches Revolutionary timsOmniTM Mass Spectrometer

May 30, 2025, 8:00 AM EDT - 1 year ago

Bruker Launches Revolutionary timsOmniTM Mass Spectrometer


Bruker Transcript: AGM 2025

May 29, 2025, 10:00 AM EDT - 1 year ago

Bruker Transcript: AGM 2025


Bruker Proxy statement: Proxy Filing

May 19, 2025, 8:00 AM EDT - 1 year ago

Bruker Proxy statement: Proxy Filing


Bruker Earnings Call Transcript: Q1 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Bruker Earnings Call Transcript: Q1 2025


Bruker Quarterly report: Q1 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Bruker Quarterly report: Q1 2025


Bruker Earnings release: Q1 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Bruker Earnings release: Q1 2025


Bruker Slides: Q1 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Bruker Slides: Q1 2025


Bruker Reports First Quarter 2025 Financial Results

May 7, 2025, 7:00 AM EDT - 1 year ago

Bruker Reports First Quarter 2025 Financial Results


Esau815
Esau815 Jun. 20 at 11:17 PM
$BRKR Wait a minute. Just read the proxy. Jack Phillips is the "accomplished executive" who is new to the Board??? He's the guy who bankrupted AXDX! How did he get this soft landing?
0 · Reply
Thos01
Thos01 Jun. 18 at 5:52 PM
$BRKR damn this looks pretty good
0 · Reply
SuperGreenToday
SuperGreenToday Jun. 16 at 10:03 PM
$BRKR Share Price: $55.79 Contract Selected: Dec 18, 2026 $55 Calls Buy Zone: $8.50 – $10.50 Target Zone: $13.61 – $16.64 Potential Upside: 51% ROI Time to Expiration: 184 Days | Updates via https://fxcapta.com/stockinfo/
1 · Reply
MarketBeat
MarketBeat Jun. 6 at 8:03 PM
https://marketbeat.com/a/8696951/ $BRKR Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam
0 · Reply
YoloSqueeze
YoloSqueeze Jun. 3 at 2:46 PM
$SMCI if we wanted to move, we would be doing what $BRKR is doing
0 · Reply
DavyDaveCharts
DavyDaveCharts May. 28 at 3:54 PM
$BRKR 18% in 7 days.
0 · Reply
DavyDaveCharts
DavyDaveCharts May. 21 at 9:13 PM
$BRKR monthly: nice bounce from the bullish imbalance. looking at 56 as a draw on liquidity. Momentum indicators are bullish.
0 · Reply
stockpicker63
stockpicker63 May. 6 at 6:58 PM
Watch $BRKR
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 6 at 10:37 AM
$BRKR Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.02 down -81.82% YoY • Reported revenue of $823.4M up 2.75% YoY • Bruker reconfirms FY2026 guidance, expecting revenues of $3.57B, an increase of 4% to 5% year-over-year, with 1% to 2% organic growth. Non-GAAP EPS is projected to be $2.10 to $2.15, up 15% to 17% year-over-year.
0 · Reply
Ren_Stimpy
Ren_Stimpy May. 1 at 11:59 AM
$STIM $BRKR $BIO $AHCO $ENOV this is just a few examples of companies in the medical device industry that sold more of their shares than they currently have. Add up the percentage of institutional, insiders and shares shorted. All well over 💯 percent!! How will the short sellers buy back shares that don’t exist? I think short sellers are in trouble of losing big betting against this industry.
0 · Reply
CHItraders
CHItraders Apr. 17 at 1:15 PM
$BRKR Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 31 at 2:44 AM
$BRKR Share Price: $34.31 Contract Selected: Sep 18, 2026 $35 Calls Buy Zone: $4.17 – $5.15 Target Zone: $7.07 – $8.65 Potential Upside: 60% ROI Time to Expiration: 171 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
topstockalerts
topstockalerts Mar. 17 at 5:18 PM
Shares of Bruker Corporation and 10x Genomics fell after Satya Nadella highlighted GigaTIME, an AI model developed by Microsoft, Providence Health, and the University of Washington that can predict multiplex immunofluorescence results from H&E pathology slides. The selloff reflected concerns that AI could reduce demand for spatial proteomics, but Wolfe Research argued the reaction was overdone, noting these tools are not yet widely used in clinical settings and the underlying study was published months ago in Cell. GigaTIME uses multimodal AI trained on 40 million cells and tested across 14,000+ patients, analyzing 21 protein markers including PD-L1. However, Wolfe said this marker set is relatively limited compared to traditional methods, suggesting the technology remains early-stage rather than a near-term replacement. $BRKR $TXG
2 · Reply
BillionerOfKing
BillionerOfKing Mar. 4 at 7:26 PM
$BRKR Current Stock Price: $38.94 Contracts to trade: $40.0 BRKR Mar 20 2026 Call Entry: $1.15 Exit: $2.09 ROI: 81% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JackDarwin
JackDarwin Feb. 24 at 11:50 AM
$BRKR Bullish Engulfing Candlestick Pattern
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 20 at 6:23 PM
$BRKR Share Price: $38.06 Contract Selected: Sep 18, 2026 $45 Calls Buy Zone: $3.15 – $3.89 Target Zone: $5.05 – $6.17 Potential Upside: 52% ROI Time to Expiration: 209 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MaryThomas194
MaryThomas194 Feb. 18 at 12:42 PM
$BRKR Life sciences tools leader benefiting from research spend normalization.
0 · Reply
alshamiak
alshamiak Feb. 12 at 6:30 PM
$BRKR #swing edit: 33.32 https://usastockhunteracademy.com/en/swing-indicator-vip/
0 · Reply
sweetpotatocow
sweetpotatocow Feb. 12 at 2:28 PM
$BRKR picked the wrong horse to bet on for ER pop. 😞
0 · Reply